Skip to main content

Peer Review reports

From: A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01)

Original Submission
12 Apr 2020 Submitted Original manuscript
13 Apr 2020 Author responded Author comments - Osamu Itano
Resubmission - Version 2
13 Apr 2020 Submitted Manuscript version 2
19 May 2020 Reviewed Reviewer Report
31 May 2020 Reviewed Reviewer Report
20 Jun 2020 Author responded Author comments - Osamu Itano
Resubmission - Version 3
20 Jun 2020 Submitted Manuscript version 3
2 Jul 2020 Author responded Author comments - Osamu Itano
Resubmission - Version 4
2 Jul 2020 Submitted Manuscript version 4
14 Jul 2020 Author responded Author comments - Osamu Itano
Resubmission - Version 5
14 Jul 2020 Submitted Manuscript version 5
Publishing
15 Jul 2020 Editorially accepted
23 Jul 2020 Article published 10.1186/s12885-020-07185-6

You can find further information about peer review here.

Back to article page